DIY Laboratories and business innovation ecosystems: The case of pharmaceutical industry

Qiang Wu, Qile He*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


This paper conducts an embedded case study to verify a conceptual framework by which biopharma research in Do-It-Yourself (DIY) laboratories can be integrated into Research and Development (R&D) networks of the pharmaceutical industry. As an early attempt to extend the perspective of business innovation ecosystem into the research on DIY laboratories, this study reveals three major findings. First, DIY laboratories, contract research organizations (CROs) and pharmaceutical firms interdependently position and link with each other in an innovation ecosystem for new drug development. Second, through properly managing the issues of resource utilization and innovation appropriability, CROs play important hub and knowledge broker roles in coordinating and aligning different priorities and expectations of the key players in this innovation ecosystem. Third, this study maps and verifies two knowledge transfer models through which novel research findings in DIY laboratories can be converted into real commercial returns.
Original languageEnglish
Article number120336
JournalTechnological Forecasting and Social Change
Early online date25 Sept 2020
Publication statusPublished - 1 Dec 2020

Bibliographical note

© 2020, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International


  • Contract research organization (CRO)
  • DIY laboratory
  • Innovation ecosystem
  • Pharmaceutical R&D
  • Pharmaceutical firm


Dive into the research topics of 'DIY Laboratories and business innovation ecosystems: The case of pharmaceutical industry'. Together they form a unique fingerprint.

Cite this